-
Mashup Score: 2Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice - 1 day(s) ago
This clinical insights article is derived from recommendations in Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update. This document is based on an ASCO Guideline and is not intended to substitute for the independent professional judgment of the treating physician. Practice guidelines do not account for individual variation among patients. This article does not purport to suggest any particular course of medical treatment. Use of the guideline and this article are
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 13JCO Oncology Practice: Vol 21, No 1 - 2 day(s) ago
Listen to the inaugural episode “Debt or Dying” with Dr. Fumiko Chino and Dr. Ryan
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 9
Host Dr. Fumiko Chino sits down with co-editor and health outcomes researcher Dr. Ryan Nipp, and contributing author Dr. Kelly Shanahan who is living with metastatic breast cancer to have a candid conversation about financial toxicity, the lived experience for patients, and what we can do to move the needle on affordability in cancer care.
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet-
Listen to the inaugural episode of JCO OP: Put into Practice! Host @fumikochino sits down w/ co-editor & health outcomes researcher Dr. Ryan Nipp, & author Dr. Kelly Shanahan to talk financial toxicity in #cancercare & the lived experience for patients. https://t.co/4Bi8YBXeHS https://t.co/JQuwy9Nby1
-
-
Mashup Score: 1
PURPOSENational Comprehensive Cancer Network Guidelines recommend initiating postoperative radiation therapy (PORT) within 6 weeks of surgery for patients with head and neck squamous cell carcinoma (HNSCC), but delays affect 50% of patients, …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1Debt or Dying: The High Costs of Cancer Care in America, One Patient's Perspective | JCO Oncology Practice - 3 day(s) ago
My name is Kelly Shanahan and I have been living with—or as I like to say #NotDeadYet—with metastatic breast cancer (MBC) for 10 years. In 2008, I had everything going for me: a graduate of Bryn Mawr College and the University of Virginia School of Medicine, I had a busy and successful obstetrics and gynecolog y practice in South Lake Tahoe, CA; a precocious 9-year-old daughter; and a well-used passport from traveling all over the world with my family to attend conferences, with a liberal dose of
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 7
PURPOSEFood insecurity is prevalent among patients with cancer. Gaps in our understanding of preferences for food assistance among Latino or Hispanic, immigrant, and people with multiple races and ethnicities limit uptake of food assistance interventions …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
PURPOSEPatient-controlled analgesia (PCA) has been considered for managing cancer pain; however, limited research has been conducted on optimizing continuous infusion rates with PCA. This study aimed to evaluate the efficacy and safety of a method that …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0
PURPOSEThe treatment landscape for metastatic renal cell carcinoma (mRCC) has evolved in recent years with the use of tyrosine kinase inhibitors (TKIs) and immuno-oncology (IO) therapies. This study examined patient characteristics, treatment patterns, …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 19Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials | JCO Oncology Practice - 8 day(s) ago
PURPOSEThis study aimed to determine complete toxicity reporting (CTR), and the use of subjective toxicity-minimizing language (TML) among phase III oncology trials.METHODSTwo-arm superiority-design phase III oncology trials published from 2002 to 2020 …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Concomitant Statin Use and Survival in Patients With Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis | JCO Oncology Practice - 9 day(s) ago
PURPOSEThe prognostic significance of concomitant statin use in cancer treatment with immune checkpoint inhibitors (ICIs) remains a subject of ongoing investigation. This study aims to clarify the prognostic value of statin use in this patient population …
Source: ascopubs.orgCategories: General Medicine News, Oncologists1Tweet
Now available: clinical insights on neoadjuvant chemotherapy for newly diagnosed, advanced #ovariancancer. #OncTwitter #gynonc Learn more: https://t.co/xnmhW6ogwm